Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action.
about
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma)Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approachDigital vascular responses and serum endothelin-1 concentrations in primary and secondary Raynaud's phenomenon.Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynauds phenomenon.No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis.Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis.Plasma endothelin-1 levels in patients with systemic sclerosis: influence of pulmonary or systemic arterial hypertension.Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosisAutoimmunity and vascular involvement in systemic sclerosis (SSc).A cytokine reborn? Endothelin-1 in pulmonary inflammation and fibrosis.Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis.Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis.Vascular involvement in systemic sclerosis (scleroderma).Host-mediated modification of PvuII restriction in Mycobacterium tuberculosisClinical comments and a pathophysiological discussion of scleroderma.Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease.Role of endothelin in fibrosis and anti-fibrotic potential of bosentan.Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?Endothelin-1 in idiopathic pulmonary fibrosis.IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokinesIncreased serum levels of fractalkine and mobilisation of CD34+CD45- endothelial progenitor cells in systemic sclerosis.Endothelin in pulmonary fibrosis.Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension.The association between systemic sclerosis, arginine and asymmetric dimethylarginine.Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.Tissue plasminogen activator treatment of digital thrombosis in severe Raynaud's phenomenon--a case report.Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study.Digital ulcers in scleroderma patients: A retrospective observational study.Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis.Adhesion molecules in scleroderma: collagen binding integrins.The vascular endothelium in scleroderma.Raynaud's phenomenon and scleroderma. Dysregulated neuroendothelial control of vascular tone.Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?Improvement of plasma endothelin-1 and nitric oxide in patients with systemic sclerosis by bosentan therapy.Abnormal nitric oxide metabolism in systemic sclerosis: increased levels of nitrated proteins and asymmetric dimethylarginine.Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis.Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.Airway responsiveness to inhaled albuterol in patients with pulmonary hypertension.
P2860
Q24796737-F8DDCCE1-B2C1-4691-9D1B-91FC818069EBQ24814682-CEB2223A-F91A-4D3A-83E8-2740BD8A1E3EQ30951684-0B4E5B0A-0180-4260-8374-DEDECCDF5BDCQ33230678-12EE9557-02A0-49F0-B699-DF43670A94F8Q33427439-41D3B431-D722-463E-9BD6-4992BB4CC314Q33566537-F5EB801C-1C09-4C72-9FF8-25ADD2595E23Q33578329-38ABE8F2-8C69-4BB9-B8A4-471026E85836Q33687299-259DFE6E-3BBA-4731-B3AF-BAEF964838DCQ33792303-107FAAF5-49B4-4A1B-B9DD-76DA701A8DC4Q33876515-41D39D2B-4541-4BEC-93FC-93049ED1F252Q33954012-0B61D234-5F2B-480D-91A7-1EB2E379F82CQ35495068-F1EE13E8-EFB0-484E-80D5-921F9F92A3D0Q35553296-49990DE0-9BCD-434C-A2F7-8963881994CAQ35557424-7E0C7181-35C9-407D-9A9A-EE959376012DQ35600359-ACEC4318-8362-4A22-A121-6D49BB3E6A65Q35654907-89B2A8CA-656E-42C1-AD25-BD4453251467Q35763490-21756369-1D0A-41CF-A0CB-5C38856909FFQ36132271-B7B4736B-6B73-419D-9995-73C7D1E843F3Q36261523-FF7F12F0-713B-4E36-88FE-E7450E008C85Q36836706-7F866B96-71C2-48D6-B917-C3ABAD23F846Q37260266-A4EBD55A-FD6C-413C-9386-C449F15B1B0AQ37351068-461AA182-6121-4DE8-8732-82FD5106A428Q37713525-C37EC927-4F5D-47D0-86E6-5D78C5F33689Q37744240-78113244-E6BC-4459-BD78-D421BCFF4CA8Q37866804-0E68E23E-C50E-4461-8FF9-A334E8930F1FQ38254026-63823AD5-573C-4971-B44F-A51A5AEAC53AQ38909892-4E1E4370-4A55-4FFA-8DA6-F4A35188E759Q39407719-4A9305D5-16E4-4CF2-AE4D-D700E4BF1106Q39966988-42F3F6BE-3FE3-4439-818E-B42D5DBDEC11Q40192330-C95E846B-3145-43AE-8A58-19366640D9ADQ40382703-18335F76-621C-439F-AF4A-84A3F7216272Q40403505-86578A62-3CCE-4894-B9D4-97C72D3AB7CEQ40468545-9507497D-A09C-4E4D-832D-3354DB0C66F0Q40567511-C069C6BE-D37E-4CCE-8DEF-61AAA25B5DD7Q42944137-4D7E146F-4D58-462F-AFF2-8B775FC50C9EQ44658816-4C92B614-9D4A-4ED8-8E2B-55BDCC8CAEC5Q46884670-54B2F11C-74A4-47A2-89E4-18AA7339A78FQ53266606-ED9B86C7-70C1-46E0-945A-EC3F2A49F2A1Q53594263-D2AB4BC1-779A-4161-81A3-633429665394Q54106913-02A07F7E-8C39-4CC6-8ED3-571180A2A6B4
P2860
Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@en
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@nl
type
label
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@en
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@nl
prefLabel
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@en
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@nl
P356
P1476
Endothelin, an endothelial-dep ...... uction and profibrotic action.
@en
P2093
Kahaleh MB
P2860
P304
P356
10.1002/ART.1780340807
P577
1991-08-01T00:00:00Z